scholarly journals The Influences of Withdrawal and Daily Dose Reduction of Pioglitazone on Metabolic Parameters in Patients With Type 2 Diabetes: A Retrospective Longitudinal Observational Study

2016 ◽  
Vol 8 (8) ◽  
pp. 585-590 ◽  
Author(s):  
Hisayuki Katsuyama ◽  
Takayuki Fukunaga ◽  
Hidetaka Hamasaki ◽  
Hiroki Adachi ◽  
Sumie Moriyama ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Observational Study ◽  
Dose Reduction ◽  
Metabolic Parameters ◽  
Longitudinal Observational Study ◽  
Daily Dose

Abstract #1223 Artificial Intelligence Powered Coaching to Drive Self Monitoring of Blood Glucose: Longitudinal Observational Study with People Living with Type-2 Diabetes

2018 ◽  
Vol 24 ◽  
pp. 317-318
Author(s):  
Maaz Shaikh ◽  
Abhishek Shah ◽  
Neeta Deshpande ◽  
Tejal Lathia ◽  
Rajeev Kovil ◽  
...  
Keyword(s):  
Artificial Intelligence ◽  
Type 2 Diabetes ◽  
Blood Glucose ◽  
Observational Study ◽  
Self Monitoring ◽  
Longitudinal Observational Study

Conversational Artificial Intelligence for Achieving Activity Targets through Routine Physical Activity—Longitudinal Observational Study among People with Type 2 Diabetes

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 750-P
Author(s):  
BRIJ M. MAKKAR ◽  
MAAZ SHAIKH ◽  
ABHISHEK SHAH ◽  
SHILPA JOSHI ◽  
BANSHI D. SABOO ◽  
...  
Keyword(s):  
Physical Activity ◽  
Artificial Intelligence ◽  
Type 2 Diabetes ◽  
Observational Study ◽  
Longitudinal Observational Study

scholarly journals Relationships between oral hypoglycemic drugs and memory decline in people with type 2 diabetes: A stratified longitudinal observational study

2020 ◽  
Vol 16 (S6) ◽  
Author(s):  
Che‐Yuan Wu ◽  
Michael Ouk ◽  
Yuen Yan Wong ◽  
Natasha Anita ◽  
Jodi D. Edwards ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Observational Study ◽  
Memory Decline ◽  
Longitudinal Observational Study ◽  
Oral Hypoglycemic Drugs

High ACR level is a strong risk factor for renal tubular impairment in patients with type 2 diabetes: A longitudinal observational study

2020 ◽  
Vol 165 ◽  
pp. 108272
Author(s):  
Huabin Wang ◽  
Wenxia Xu ◽  
Caiqun Huang ◽  
Ying Liu ◽  
Lude Wang ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Risk Factor ◽  
Observational Study ◽  
Strong Risk Factor ◽  
Longitudinal Observational Study ◽  
Renal Tubular

scholarly journals Plasma triglycerides predict ten-years all-cause mortality in outpatients with type 2 diabetes mellitus: a longitudinal observational study

2014 ◽  
Vol 13 (1) ◽  
Author(s):  
Maria-Agata Miselli ◽  
Edoardo Dalla Nora ◽  
Angelina Passaro ◽  
Franco Tomasi ◽  
Giovanni Zuliani
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Observational Study ◽  
Plasma Triglycerides ◽  
Longitudinal Observational Study ◽  
All Cause Mortality

scholarly journals Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998–2004: a longitudinal observational study

2007 ◽  
Vol 6 (1) ◽  
pp. 25 ◽  
Author(s):  
Jacoba P Greving ◽  
Petra Denig ◽  
Dick de Zeeuw ◽  
Henk JG Bilo ◽  
Flora M Haaijer-Ruskamp
Keyword(s):  
Type 2 Diabetes ◽  
Observational Study ◽  
Hypertension Management ◽  
Longitudinal Observational Study ◽  
Diabetes Patients

No effect of vitamin D supplementation on metabolic parameters but on lipids in patients with type 2 diabetes and chronic kidney disease

2020 ◽  
pp. 1-10
Author(s):  
Jiwoon Kim ◽  
Ji Sun Nam ◽  
Heejung Kim ◽  
Hye Sun Lee ◽  
Jung Eun Lee
Keyword(s):  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Vitamin D ◽  
Kidney Disease ◽  
Vitamin D Supplementation ◽  
Lipid Profiles ◽  
Metabolic Parameters ◽  
Injection Group ◽  
Different Doses

Abstract. Background/Aims: Trials on the effects of cholecalciferol supplementation in type 2 diabetes with chronic kidney disease patients were underexplored. Therefore, the aim of this study was to investigate the effects of two different doses of vitamin D supplementation on serum 25-hydroxyvitamin D [25(OH)D] concentrations and metabolic parameters in vitamin D-deficient Korean diabetes patients with chronic kidney disease. Methods: 92 patients completed this study: the placebo group (A, n = 33), the oral cholecalciferol 1,000 IU/day group (B, n = 34), or the single 200,000 IU injection group (C, n = 25, equivalent to 2,000 IU/day). 52% of the patients had less than 60 mL/min/1.73m2 of glomerular filtration rates. Laboratory test and pulse wave velocity were performed before and after supplementation. Results: After 12 weeks, serum 25(OH)D concentrations of the patients who received vitamin D supplementation were significantly increased (A, -2.4 ± 1.2 ng/mL vs. B, 10.7 ± 1.2 ng/mL vs. C, 14.6 ± 1.7 ng/mL; p < 0.001). In addition, the lipid profiles in the vitamin D injection group (C) showed a significant decrease in triglyceride and a rise in HDL cholesterol. However, the other parameters showed no differences. Conclusions: Our data indicated that two different doses and routes of vitamin D administration significantly and safely increased serum 25(OH)D concentrations in vitamin D-deficient diabetes patients with comorbid chronic kidney disease. In the group that received the higher vitamin D dose, the lipid profiles showed significant improvement, but there were no beneficial effects on other metabolic parameters.

Sign in / Sign up

Export Citation Format

Share Document